Better, faster, cheaper – the future of US healthcare?
Speaker: Mike Spencer
Date/Time: Friday, November 6th, 8:00-10:00 AM, presentation begins at 8:30 sharp
Place: Genentech, 42-1D in Bldg 42
475 East Grand Avenue
South San Francisco 94080
(Admission is free, but registration is required by 10:00 AM 11/4)
Mike Spencer is the Administrative Director of the Performance Improvement department at Stanford Children’s Health (SCH) & Lucile Packard Children’s Hospital (LPCH). At SHC and LPCH, the PI department facilitates SCH’s transformation to a lean management system – with a true north vision of providing “nurturing care, extraordinary outcomes for healthier, happy lives”.
Mike joined Stanford in 2011 coming from Bay Area biotech pioneer Genentech where he was both Director of Business Integration Management and Director of Project Management in Development Sciences from 2003 - 2010. Prior to his roles at Genentech, Mike held multiple leadership roles in supply chain management, management consulting, and project management.
Mike brings to SCH/LPCH a broad set of skills garnered from careers across multiple industries & multiple functions. He considers himself a generalist whose skills complement the scientific & medical experts in outstanding organizations such as Stanford, Genentech & Raychem.
Two common threads run through Mike’s roles: continuous improvement through collaboration, and building sustainable organizational capabilities.
Formative experiences include his current role as change agent for lean in healthcare; extending project management capability within scientific groups in biotechnology; improving quality and delivery times in multinational high-tech manufacturing.
US healthcare costs consistently rank as the most expensive in the world, with outcomes & satisfaction far down the ranking.
Many hospitals & healthcare systems are aggressively implementing lean management systems, to sustainably eliminate waste, improve care & increase patient satisfaction. Lean principles, directly based on decades of experience in manufacturing & other industries, have been proven to complement both the science & the art of medicine.
What if we could reduce total drug development time by 20 or 30%? The resultant benefits would be huge - to society in getting drugs to patients faster, & to biopharma in reversing the otherwise inexorable increases in costs.
By examining micro-level lean improvement in healthcare, we can explore the impact on macro-drug development processes.
Register early, you won't want to miss this!